High-throughput, automated analysis of viral vector titer and process related impurities accelerates downstream process development of AAV based gene therapies

Viral vector production is a labor and resource-intensive process that often results in small batches of highly valuable product. Quantification of titer and impurities levels are important critical quality attributes that can consume a lot of sample and take considerable time to perform.

Download the poster to learn how AAV titer and three different impurities assays were performed in one single run on Gyrolab^® xPand requiring minimal hands-on time and sample volume.

If you have problems downloading the poster, please contact maritha.lundin@gyrosproteintech.com